This data also suggests our 5’MYC gain case could be included in “double-hit” lymphoma, but given the overall lack of data and consensus in the literature at this point, the 5’MYC gain case was not included in the “double-hit” lymphoma category for our study. Here, MYC is linked to lymphoma.